Table 2 Multivariable logistic regression analyses * for point prevalence abstinence † , 6-month continuous abstinence † , and sustained abstinence
Point prevalence abstinence † | |||
|---|---|---|---|
Variable | OR | 95% CI for OR | p-value |
‡ Program; HIT vs. LIT (ref) | 1.21 | 0.59-2.49 | .599 |
‡ Gender; men vs. women (ref) | 0.54 | 0.20-1.46 | .226 |
‡ Point prevalence at 12-month follow-up; yes vs. no (ref) | 13.82 | 6.44–29.65 | <.001 |
‡ Other support at 12-month follow-up; yes vs. no (ref) | 4.37 | 1.13–16.95 | .033 |
§ Program; HIT vs. LIT (ref) | 1.12 | 0.56-2.26 | .751 |
§ Gender; men vs. women (ref) | 0.67 | 0.26-1.71 | .405 |
§ 6-month continuous abstinence at 12-month follow-up; yes vs. no (ref) | 13.53 | 5.66–32.32 | <.001 |
§ Other support at 12-month follow-up; yes vs. no (ref) | 4.95 | 1.30–18.85 | .019 |
6-month continuous abstinence † | |||
Variable | OR | 95% CI for OR | p-value |
║ Program; HIT vs. LIT (ref) | 1.26 | 0.65-2.43 | .487 |
║ Gender; men vs. women (ref) | 0.55 | 0.23-1.35 | .193 |
║ Point prevalence at 12-month follow-up; yes vs. no (ref) | 14.10 | 7.05–28.19 | <.001 |
¶ Program; HIT vs. LIT (ref) | 1.10 | 0.57-2.13 | .779 |
¶ Gender; men vs. women (ref) | 0.62 | 0.26-1.51 | .297 |
¶ 6-month continuous abstinence at 12-month follow-up; yes vs. no (ref) | 18.70 | 8.30–42.16 | <.001 |
Sustained abstinence ** | |||
Variable | OR | 95% CI for OR | p-value |
Program; HIT vs. LIT (ref) | 3.44 | 1.34–8.83 | .010 |
Gender; men vs. women (ref) | 1.21 | 0.41-3.60 | .733 |